Jiangsu HengRui Medicine Co., Ltd.: Arthritis, Rheumatoid trials
The registry lists 10 Arthritis, Rheumatoid studies with Jiangsu HengRui Medicine Co., Ltd. as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 8Phase 2 1Phase 3 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy SubjectsCompletedNCT07200596Phase 1
- A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy SubjectsCompletedNCT06883695Phase 1
- Study on the Pharmacokinetic Effect of Itraconazole on SHR0302 Tablets in Healthy SubjectsCompletedNCT05404724Phase 1
- A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healthy VolunteersCompletedNCT05392127Phase 1
- A Study of Human Substance Balance and Biotransformation of [14C]SHR0302CompletedNCT05047341Phase 1
- A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid ArthritisCompletedNCT04333771Phase 3
- Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) PatientsCompletedNCT03254966Phase 2
- Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy SubjectsStatus unknownNCT02892370Phase 1
- Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) PatientsStatus unknownNCT02665910Phase 1
- First-in-Human Single Ascending Dose of SHR0302Status unknownNCT02423538Phase 1